Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues

INTRODUCTION: During treatment with protease inhibitor monotherapy, the number of antiretrovirals with therapeutic concentrations in the cerebrospinal fluid (CSF) is lower, compared to standard triple therapy. However, the clinical consequences are unclear. METHODS: A total of 273 patients with HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Amanda, Johanssen, Veronika, Gerstoft, Jan, Clotet, Bonaventura, Ripamonti, Diego, Murungi, Andrew, Bicer, Ceyhun, Blanca Hadacek, Maria, Moecklinghoff, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Oral Presentation – Abstract O423B
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224914/
https://www.ncbi.nlm.nih.gov/pubmed/25394035
http://dx.doi.org/10.7448/IAS.17.4.19526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224914/
https://www.ncbi.nlm.nih.gov/pubmed/25394035
http://dx.doi.org/10.7448/IAS.17.4.19526

Ejemplares similares